Literature DB >> 17980576

Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register.

Alessandro Marinaccio1, Alessandra Binazzi, Gabriella Cauzillo, Domenica Cavone, Renata De Zotti, Pierpaolo Ferrante, Valerio Gennaro, Giuseppe Gorini, Massimo Menegozzo, Carolina Mensi, Enzo Merler, Dario Mirabelli, Fabio Montanaro, Marina Musti, Franco Pannelli, Antonio Romanelli, Alberto Scarselli, Rosario Tumino.   

Abstract

Italy was an important producer of raw asbestos until 1992 (when it was banned) and it is now experiencing severe public health consequences due to large-scale industrial use of asbestos in shipbuilding and repair, asbestos-cement production, railways, buildings, chemicals and many other industrial sectors. Latency of malignant mesothelioma generally shows a large variability and the relationship with the modality of asbestos exposure is still not fully clarified. We present an analysis of latency period among the case list collected by the Italian mesothelioma register (ReNaM) in the period of diagnosis 1993-2001 (2544 malignant mesothelioma (MM) cases with asbestos exposure history). Exposure is assessed retrospectively by interview. Statistical univariate analyses were performed to estimate median and variability measures of latency time by anatomical site, gender and diagnosis period. The role of diagnostic confidence level, the morphology of the tumour and the modalities of asbestos exposure were verified in a regression multivariate model. We found a median latency period of 44.6 years increasing in recent years with a linear trend. Anatomical site, gender and morphology were not relevant for MM latency time whereas a shorter latency period was documented among occupationally exposed subjects (43 years) with respect to environmentally and household exposed ones (48 years).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980576     DOI: 10.1016/j.ejca.2007.09.018

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  39 in total

1.  BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.

Authors:  Yosuke Morodomi; Tokujiro Yano; Hiroaki Kinoh; Yui Harada; Satoru Saito; Ryoichi Kyuragi; Kumi Yoshida; Mitsuho Onimaru; Fumihiro Shoji; Tsukihisa Yoshida; Kensaku Ito; Yasunori Shikada; Riichiroh Maruyama; Mamoru Hasegawa; Yoshihiko Maehara; Yoshikazu Yonemitsu
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

2.  Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.

Authors:  Vasiliki Panou; Meghana Gadiraju; Arthur Wolin; Caroline M Weipert; Emily Skarda; Aliya N Husain; Jyoti D Patel; Buerkley Rose; Shannon R Zhang; Madison Weatherly; Viswateja Nelakuditi; Amy Knight Johnson; Maria Helgeson; David Fischer; Arpita Desai; Nanna Sulai; Lauren Ritterhouse; Oluf D Røe; Kiran K Turaga; Dezheng Huo; Jeremy Segal; Sabah Kadri; Zejuan Li; Hedy L Kindler; Jane E Churpek
Journal:  J Clin Oncol       Date:  2018-08-16       Impact factor: 44.544

3.  The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey.

Authors:  Serdar Berk; Huseyin Yalcin; Omer Tamer Dogan; Kursat Epozturk; Ibrahim Akkurt; Zehra Seyfikli
Journal:  Environ Geochem Health       Date:  2013-04-04       Impact factor: 4.609

Review 4.  Management of malignant pleural mesothelioma-The European experience.

Authors:  Isabelle Opitz
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

5.  Awareness: potential toxicities of carbon nanotubes.

Authors:  Nico van Zandwijk; Arthur L Frank
Journal:  Transl Lung Cancer Res       Date:  2019-12

6.  Pleural and peritoneal mesotheliomas in the Friuli Venezia Giulia register: data analysis from 1995 to 2015 in Northeastern Italy.

Authors:  Flavia D'Agostin; Paola De Michieli; Carolin Chermaz; Corrado Negro
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 7.  Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.

Authors:  Lisa Brusselmans; Lieselot Arnouts; Charissa Millevert; Joyce Vandersnickt; Jan P van Meerbeeck; Kevin Lamote
Journal:  Transl Lung Cancer Res       Date:  2018-10

8.  Malignant pleural mesothelioma in Italy.

Authors:  Claudio Bianchi; Tommaso Bianchi
Journal:  Indian J Occup Environ Med       Date:  2009-08

Review 9.  The health impact of nonoccupational exposure to asbestos: what do we know?

Authors:  Marcel Goldberg; Danièle Luce
Journal:  Eur J Cancer Prev       Date:  2009-11       Impact factor: 2.497

Review 10.  Malignant pleural mesothelioma: current and future perspectives.

Authors:  Konstantinos Porpodis; Paul Zarogoulidis; Efimia Boutsikou; Antonis Papaioannou; Nikolaos Machairiotis; Kosmas Tsakiridis; Nikolaos Katsikogiannis; Bojan Zaric; Branislav Perin; Haidong Huang; Ioanna Kougioumtzi; Dionysios Spyratos; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.